Abingdon Health PLC
LSE:ABDX

Watchlist Manager
Abingdon Health PLC Logo
Abingdon Health PLC
LSE:ABDX
Watchlist
Price: 8.4 GBX 5%
Market Cap: 16.3m GBX
Have any thoughts about
Abingdon Health PLC?
Write Note

Gross Margin
Abingdon Health PLC

57.4%
Current
-13%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
57.4%
=
Gross Profit
3.1m
/
Revenue
5.3m

Gross Margin Across Competitors

Country UK
Market Cap 16.3m GBP
Gross Margin
57%
Country JP
Market Cap 7T JPY
Gross Margin
86%
Country CH
Market Cap 37.9B CHF
Gross Margin
55%
Country DK
Market Cap 178.7B DKK
Gross Margin
68%
Country US
Market Cap 16.1B USD
Gross Margin
70%
Country KR
Market Cap 10.3T KRW
Gross Margin
15%
Country CN
Market Cap 49B CNY
Gross Margin
72%
Country US
Market Cap 6.5B USD
Gross Margin
65%
Country CA
Market Cap 6.4B USD
Gross Margin
61%
Country US
Market Cap 5.7B USD
Gross Margin
47%
Country UK
Market Cap 4.6B GBP
Gross Margin
56%
No Stocks Found

Abingdon Health PLC
Glance View

Market Cap
16.3m GBX
Industry
Health Care

Abingdon Health Plc develops, manufactures and commercializes immunoassay tests and reader systems. The company is headquartered in York, North Yorkshire and currently employs 151 full-time employees. The company went IPO on 2020-12-15. The firm operates through three segments: Contract Development, Contract Manufacturing and Product Sales. The Contract Development segment comprises development work for third parties and is recognized over time based on a proportion of completion. The Contract Manufacturing segment comprises contract development and manufacturing activities. The Product Sales segment comprises the sale of ABC-19, pocket diagnostic products, progressive rod cone degeneration (PCRD) tests and antibodies for research use. Its products also include Seralite, which includes Free Light Chain (FLC) Serum. The Company’s geographical market include the United Kingdom, the United States/Canada, rest of world (ROW).

ABDX Intrinsic Value
11.84 GBX
Undervaluation 29%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
57.4%
=
Gross Profit
3.1m
/
Revenue
5.3m
What is the Gross Margin of Abingdon Health PLC?

Based on Abingdon Health PLC's most recent financial statements, the company has Gross Margin of 57.4%.